News

Mylan`s Generic Lipitor Receives Tentative FDA Approval

02/03/2012

Mylan, Inc. has received tentative approval from the US Food and Drug Administration to sell a generic version of Lipitor (atorvastatin), the best-selling drug from Pfizer, Inc. that lost its patent protection last November. In a news release, Mylan said it plans on selling 10 mg, 20 mg, 40 mg, and 80 mg versions of the drug. There are currently 2 generic versions of atorvastatin available. Watson Pharmaceuticals, Inc. sells an authorized copy of atorvastatin, while Ranbaxy Laboratories, Ltd. also has a generic competitor. Teva Pharmaceuticals has announced it also plans on selling a generic version of the drug. Mylan's news release can be found at https://investor.mylan.com/releases.cfm -Tim Casey

Current Issue

September 2024

Volume 21

Issue 3

Current Issue

Issue Archive

What's Trending?

News

Marketplace Consumers Likely to Find Substantial Premium Hikes This Time Around

11/20/2015

A recent report found that 231 policies were requesting double-digit hikes in premium prices. Of them, 26 policies were requesting a minimum premium hike of ≥40%.

A recent report found that 231...

11/20/2015

First Report Managed Care

News

Dairy, Gluten Show No Major Effect on MS Activity and Quality of Life

02/15/2024

Jolynn Tumolo ;

Dairy and gluten intake had no substantial effects on disease activity and quality of life in a retrospective study of 186 patients with multiple sclerosis (MS). Researchers published their findings online in Multiple Sclerosis Journal –...

Dairy and gluten intake had no...

02/15/2024

First Report Managed Care

News

No Winner for President Yet, Health Care Hangs in the Balance

11/04/2020

With the presidential election still undecided, it is also up in the air whether the federal government will play a stronger role in financing and setting the ground rules for health care coverage or cede more authority to states and the...

With the presidential election...

11/04/2020

First Report Managed Care

News

New regulation seeks to reward hospitals for quality of care

01/10/2011

First Report Managed Care

Conference Insider

Payer Decisions: Patient-Reported Outcomes, Clinical Outcome Assessments Seldom Used

05/17/2019

Within the health care decision-making process, the impact of patient-reported outcomes (PRO) and clinical outcome assessments (COAs) on payers is often low, despite efforts to include the patient voice, according to recent survey results...

Within the health care...

05/17/2019

First Report Managed Care

Video Insights

Videos

Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care

11/13/2024

David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...

David Sand, MD, MBA, chief...

11/13/2024

First Report Managed Care

Videos

The Evolving Role of CGRP-targeting Therapies in Migraine Prevention

10/31/2024

Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.

Richard Lipton, MD, provides...

10/31/2024

First Report Managed Care

Videos

Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer

09/26/2024

Alexander Spira , MD, PhD;

Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).

Alexander I. Spira, MD, PhD,...

09/26/2024

First Report Managed Care

Videos

Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives

09/25/2024

Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.

Learn about research...

09/25/2024

First Report Managed Care

Videos

Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable

09/04/2024

View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.

View a roundtable discussion on...

09/04/2024

First Report Managed Care

Videos

Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions

08/15/2024

Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...

Guest expert Jordan Bazinsky...

08/15/2024

First Report Managed Care

Videos

Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia

08/14/2024

Farrukh T. Awan , MD;

Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).

Farrukh Awan, MD, highlights...

08/14/2024

Journal of Clinical Pathways

Videos

Evolving Health Care Contact Centers Into Drivers of Value-Based Care

07/31/2024

Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.

Discover how health care contact...

07/31/2024

First Report Managed Care

Videos

Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024

06/11/2024

Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations

Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...

Key stakeholders in the health...

06/11/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

Mylan`s Generic Lipitor Receives Tentative FDA Approval

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

Specialties

Events

Year Round Education

HMP Global Products